Guidance for AngioDynamics (ANGO)
| Period |
Range |
Estimate |
Revenue Range |
Revenue Estimate |
Target |
Details |
| 2013 |
$0.32 – 0.35 |
$0.33 |
$337.00M – 341.00M |
$341.40M |
= Maintained |
Details |
| 2013 |
$0.49 – 0.51 |
$0.48 |
$360.00M – 363.00M |
$356.70M |
= Maintained |
Details |
| 2013 |
$0.40 – 0.42 |
$0.50 |
N/A |
N/A |
 Lowered |
Details |
| 2013 |
$0.40 – 0.42 |
$0.40 |
$355.00M – 360.00M |
$359.75M |
= Maintained |
Details |
| 2012 |
$0.41 – 0.49 |
$0.48 |
$217.00M – 225.00M |
$216.43M |
= Maintained |
Details |
| 2012 |
$0.41 – 0.45 |
$0.44 |
$218.00M – 222.00M |
$219.90M |
= Maintained |
Details |
| 2012 |
$0.42 – 0.44 |
$0.39 |
$216.20M – 218.20M |
$216.50M |
= Maintained |
Details |
| Q4 2012 |
$0.11 – 0.13 |
N/A |
$53.50M – 55.50M |
N/A |
= Maintained |
Details |
| Q4 2012 |
$0.09 – 0.11 |
$0.10 |
$52.10M – 54.10M |
$53.08M |
= Maintained |
Details |
| Q3 2012 |
$0.09 – 0.11 |
$0.11 |
$52.00M – 54.00M |
$54.65M |
= Maintained |
Details |
| 2011 |
$0.47 – 0.50 |
$0.51 |
$0.00M |
$0.00M |
= Maintained |
Details |
| 2011 |
$0.48 – 0.50 |
$0.49 |
$217.00M – 220.00M |
$220.20M |
= Maintained |
Details |
